2nd Annual Early Phase Clinical Trials Asia 2012
Conference - Singapore
Implementing Effective Early Phase Trial Strategies in Asia to Reduce Approval Timelines, Risks and Costs from First-In-Human through Proof of Concept
In March 2011, listings of clinical trials registered in the US FDA's clinical trial registration database showed that almost 15,680 trials are currently registered in Asia. Also we have seen a significant increase in the number of early-phase clinical trials conducted in Asia, including First-in-Human, Phase I and Phase II.
What strategies are you putting in place to prevent early and late stage failures?
2nd Annual Early Phase Clinical Trials Asia 2012 is a high-level platform for pharmaceutical and biopharmaceutical company leaders in clinical development and research to find answers to regulatory, scientific and operational challenges and issues in developing early phase clinical trials in Asian markets, which include Mainland China, India, Taiwan, Korea, Hong Kong and other Southeast Asian countries.
(Courtesy of http://www.earlystageclinicaltrials.com/)
Tue, Aug 28, 2012 - Wed, Aug 29, 2012
2012, Novotel Clarke Quay Hotel, Singapore
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
